Found: 135
Select item for more details and to access through your institution.
Application of immune enhanced organoids in modeling personalized Merkel cell carcinoma research.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-17921-6
- By:
- Publication type:
- Article
Immuno-reactive cancer organoid model to assess effects of the microbiome on cancer immunotherapy.
- Published in:
- Scientific Reports, 2022, v. 12, n. 1, p. 1, doi. 10.1038/s41598-022-13930-7
- By:
- Publication type:
- Article
Immersion Bioprinting of Tumor Organoids in Multi-Well Plates for Increasing Chemotherapy Screening Throughput.
- Published in:
- Micromachines, 2020, v. 11, n. 2, p. 208, doi. 10.3390/mi11020208
- By:
- Publication type:
- Article
Impact of Three-Dimensional Vision in Laparoscopic Training.
- Published in:
- World Journal of Surgery, 2008, v. 32, n. 1, p. 110, doi. 10.1007/s00268-007-9253-6
- By:
- Publication type:
- Article
Rectal Duplication Cyst in an Adult: The Laparoscopic Approach.
- Published in:
- Journal of Laparoendoscopic & Advanced Surgical Techniques, 2002, v. 12, n. 6, p. 453, doi. 10.1089/109264202762252758
- By:
- Publication type:
- Article
ASO Visual Abstract: Survival Outcomes of Optimally Treated Colorectal Metastases–The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Survival Outcomes of Optimally Treated Colorectal Metastases: The Importance of R0 Status in Surgical Treatment of Hepatic and Peritoneal Surface Disease.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 7, p. 4264, doi. 10.1245/s10434-023-13174-3
- By:
- Publication type:
- Article
ASO Visual Abstract: Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Long-Term Survival in Patients Treated with Cytoreduction and Heated Intraperitoneal Chemotherapy for Peritoneal Mesothelioma at a Single High-Volume Center.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 5, p. 2666, doi. 10.1245/s10434-022-13061-3
- By:
- Publication type:
- Article
ASO Visual Abstract: Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy; Does It Affect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Exposure to Neoadjuvant Oxaliplatin-Containing Chemotherapy, Does it Effect Intraperitoneal Hyperthermic Chemotherapy Perfusion?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 4, p. 2486, doi. 10.1245/s10434-022-12933-y
- By:
- Publication type:
- Article
ASO Visual Abstract: Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy, Surgical Dogma or Evidence-Based Practice?
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Switching Perfusion Agents for Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: Surgical Dogma or Evidence-Based Practice?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2023, v. 30, n. 1, p. 384, doi. 10.1245/s10434-022-12392-5
- By:
- Publication type:
- Article
ASO Visual Abstract: Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Very Early Recurrence After Curative-Intent Surgery for Gastric Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 13, p. 8653, doi. 10.1245/s10434-022-12434-y
- By:
- Publication type:
- Article
ASO Visual Abstract: Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Patient-Specific Sarcoma Organoids for Personalized Translational Research: Unification of the Operating Room with Rare Cancer Research and Clinical Implications.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7354, doi. 10.1245/s10434-022-12086-y
- By:
- Publication type:
- Article
ASO Author Reflections: Sarcoma Organoids: Neutralizing the Word "Rare" in Rare Cancers.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 12, p. 7368, doi. 10.1245/s10434-022-12089-9
- By:
- Publication type:
- Article
ASO Author Reflections: When is the Best Time to Perform Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for a Recurrent Low-Grade Appendiceal Mucinous Neoplasm?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3432, doi. 10.1245/s10434-022-11515-2
- By:
- Publication type:
- Article
ASO Author Reflections: Thirty Years of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) at Wake Forest University.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3446, doi. 10.1245/s10434-022-11514-3
- By:
- Publication type:
- Article
Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Cancers with Peritoneal Metastasis: A 30-year Institutional Experience.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3436, doi. 10.1245/s10434-022-11441-3
- By:
- Publication type:
- Article
Timing of Repeat Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy for Recurrent Low-Grade Appendiceal Mucinous Neoplasms.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 6, p. 3422, doi. 10.1245/s10434-022-11440-4
- By:
- Publication type:
- Article
Repeat CRS/HIPEC: It Comes Down to Tumor Biology and Ability to Achieve a Complete CRS.
- Published in:
- 2022
- By:
- Publication type:
- Editorial
ASO Visual Abstract: Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- 2022
- By:
- Publication type:
- Abstract
Utility of Neoadjuvant Chemotherapy for Peritoneal Carcinomatosis Secondary to High-Grade Appendiceal Neoplasms for Patients Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 4, p. 2641, doi. 10.1245/s10434-021-11153-0
- By:
- Publication type:
- Article
Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 2, p. 1220, doi. 10.1245/s10434-021-10768-7
- By:
- Publication type:
- Article
Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 205, doi. 10.1245/s10434-021-10660-4
- By:
- Publication type:
- Article
ASO Visual Abstract: Development of a Prognostic Nomogram and Nomogram Software Application Tool to Predict Overall Survival and Disease-Free Survival After Curative-Intent Gastrectomy for Gastric Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
ASO Visual Abstract: Incidence, Risk Factors, and Outcomes from Conversion of Low-Grade to High-Grade Appendiceal Neoplasms for Patients Undergoing Multiple Cytoreductive Surgeries with Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Renal Function After Retroperitoneal Sarcoma Resection with Nephrectomy: A Matched Analysis of the United States Sarcoma Collaborative Database.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2021, v. 28, n. 3, p. 1690, doi. 10.1245/s10434-020-09290-z
- By:
- Publication type:
- Article
ASO Author Reflections: Patient-Derived Tumor Organoids—A Platform for a Precision Approach for Peritoneal Malignancies.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 13, p. 4961, doi. 10.1245/s10434-020-08909-5
- By:
- Publication type:
- Article
Clinical Implications of Genetic Signatures in Appendiceal Cancer Patients with Incomplete Cytoreduction/HIPEC.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 13, p. 5016, doi. 10.1245/s10434-020-08841-8
- By:
- Publication type:
- Article
Personalized Identification of Optimal HIPEC Perfusion Protocol in Patient-Derived Tumor Organoid Platform.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 13, p. 4950, doi. 10.1245/s10434-020-08790-2
- By:
- Publication type:
- Article
ASO Author Reflections: Co-cultured Lymph Node and Tumor Organoids as a Platform for the Creation of Adaptive Immunity and Predict Response to Immunotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 6, p. 1968, doi. 10.1245/s10434-020-08351-7
- By:
- Publication type:
- Article
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 6, p. 1753, doi. 10.1245/s10434-020-08316-w
- By:
- Publication type:
- Article
Model of Patient-Specific Immune-Enhanced Organoids for Immunotherapy Screening: Feasibility Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 6, p. 1956, doi. 10.1245/s10434-019-08143-8
- By:
- Publication type:
- Article
Prognostic Molecular Classification of Appendiceal Mucinous Neoplasms Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 5, p. 1439, doi. 10.1245/s10434-020-08210-5
- By:
- Publication type:
- Article
ASO Author Reflections: Patient-Reported Outcomes of Mucinous Appendiceal Cancer Improve with Oxaliplatin HIPEC.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 781, doi. 10.1245/s10434-019-08066-4
- By:
- Publication type:
- Article
Health-Related Quality of Life After Cytoreductive Surgery/HIPEC for Mucinous Appendiceal Cancer: Results of a Multicenter Randomized Trial Comparing Oxaliplatin and Mitomycin.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 3, p. 772, doi. 10.1245/s10434-019-08064-6
- By:
- Publication type:
- Article
Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 1, p. 107, doi. 10.1245/s10434-019-07634-y
- By:
- Publication type:
- Article
Effect of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Quality of Life in Patients with Peritoneal Mesothelioma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2020, v. 27, n. 1, p. 117, doi. 10.1245/s10434-019-07425-5
- By:
- Publication type:
- Article
Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 11, p. 3542, doi. 10.1245/s10434-019-07639-7
- By:
- Publication type:
- Article
In Patients with Localized and Resectable Gastric Cancer, What is the Optimal Extent of Lymph Node Dissection—D1 Versus D2 Versus D3?
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 9, p. 2912, doi. 10.1245/s10434-019-07417-5
- By:
- Publication type:
- Article
Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2019, v. 26, n. 1, p. 139, doi. 10.1245/s10434-018-7008-2
- By:
- Publication type:
- Article
ASO Author Reflections: Long-Term Survival Is Feasible After Complete CRS/HIPEC for Biphasic Peritoneal Mesothelioma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 770, doi. 10.1245/s10434-018-7028-y
- By:
- Publication type:
- Article
ASO Author Reflections: PCI is Not Predictive of Survival After Complete CRS/HIPEC for High-Grade Appendiceal Primaries.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 769, doi. 10.1245/s10434-018-7027-z
- By:
- Publication type:
- Article
Techniques for Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 8, p. 2152, doi. 10.1245/s10434-018-6336-6
- By:
- Publication type:
- Article
PCI is Not Predictive of Survival After Complete CRS/HIPEC in Peritoneal Dissemination from High-Grade Appendiceal Primaries.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 674, doi. 10.1245/s10434-017-6315-3
- By:
- Publication type:
- Article
Is Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy Justified for Biphasic Variants of Peritoneal Mesothelioma? Outcomes from the Peritoneal Surface Oncology Group International Registry.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 3, p. 667, doi. 10.1245/s10434-017-6293-5
- By:
- Publication type:
- Article
Outcomes of Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients Older than 70 Years; Survival Benefit at Considerable Morbidity and Mortality: A Reply.
- Published in:
- 2017
- By:
- Publication type:
- Letter